American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association.
Beck C. et al. (1998). Correlates of disruptive behavior in severely cognitively impaired nursing home residents. Gerontologist, 38, 189–198.
Bedford S., Melzer D. and Guralnik J. (2001). Problem behavior in the last year of life: prevalence, risks, and care receipt in older Americans. Journal of the American Geriatrics Society, 49, 590–595.
Brooke V. (1989). Nursing home life: how elders adjust. Geriatric Nursing, 10, 66–68.
Cariaga J., Burgio L., Flynn W. and Martin D. (1991). A controlled study of disruptive vocalizations among geriatric residents in nursing homes. Journal of the American Geriatrics Society, 39, 501–507.
Caselli R. J., Reiman E. M., Hentz J. G., Osborne D. and Alexander G. E. (2004). A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 320–329.
Cohen-Mansfield J. (1986). Agitated behaviors in the Elderly: II. Preliminary results in the cognitively deteriorated. Journal of the American Geriatrics Society, 34, 722–727.
Cohen-Mansfield J. and Libin A. (2004). Assessment of agitation in elderly patients with dementia: correlations between informant rating and direct observation. International Journal of Geriatric Psychiatry, 19, 881–891.
Cohen-Mansfield J. and Werner P. (1998). Predictors of aggressive behaviors: a longitudinal study in senior day care centers. Journal of Gerontology, B: Psychological Science Social Science, 53, 300–310.
Corder E. H. et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.
Craig D., Hart D. J., McCool K., McIlroy S. P. and Passmore A. P. (2004). Apolipoprotein E e4 allele influences aggressive behavior in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1327–1330.
Davignon J., Cohn J. S., Mabile L. and Bernier L. (1999). Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clinica Chimica Acta, 286, 115–143.
Eichner J., Dunn S., Perveen G., Thompson D., Stewart K. and Stroehla B. (2002). Apolipoprotein E polymorphism and cardiovascular disease: a human genome epidemiology review. American Journal of Epidemiology, 155, 487–495.
Evans D. A. et al. (1997). Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA, 277, 822–824.
Finkel S. I., Lyons J. and Anderson R. L. (1993). A brief agitation rating scale (BARS) for nursing home elderly. Journal of the American Geriatrics Society, 41, 50–52.
Folstein M. F., Folstein S. E. and McHugh P. R. (1975). Mini mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Gabryelewicz T. et al. (2002). Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dementia and Geriatric Cognitive Disorders, 14, 208–212.
Haan M. N., Shemanski L., Jagust W. J., Manolio T. A. and Kuller L. (1999). The role of APOE ϵ4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA, 282, 40–46.
Katz S. and Akpom C. A. (1976). Index of ADL. Medical Care, 14, 116–118.
Kolovou G. and Anagnostopoulou K. (2007). Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Research Review, 6, 94–108.
Kozauer N. A., Mielke M. M., Chan G. K., Rebok G. W. and Lyketsos C. G. (2008). Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics, 20, 109–123.
Mahley R. W. and Rall S. C. Jr. (1999). Is epsilon4 the ancestral human apoE allele? Neurobiology of Aging, 20, 429–430.
Raber J. (2007). Role of apolipoprotein E in anxiety. Neural Plasticity, 2007, doi: 10.1155/2007/91236
Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T. and Raber J. (2005). apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiology of Aging, 26, 637–643.
Scarmeas N. et al. (2002). Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology, 58, 1182–1188.
Shrout P. E. and Fleiss J. L. (1979). Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin, 86, 420–428.
van der Flier W. M. et al. (2007). Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dementia and Geriatric Cognitive Disorder, 23, 42–46.
Vertesi A. et al. (2001). Standardized Mini-mental State Examination: use and interpretation. Canadian Family Physician, 47, 2018–2023.
Woods D. L. and Dimond M. (2002). The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer's disease. Biological Research for Nursing, 4, 104–114.
Woods D. L., Kovach C. R., Raff H., Joosse L., Basmadjian A. and Hegadoren K. M. (2008). Using saliva to measure endogenous cortisol in nursing home residents with advanced dementia. Research in Nursing and Health, 31, 283–294.